On July 17, 2025, Clearside Biomedical, Inc. announced a workforce reduction plan resulting in all employees transitioning to consulting roles, expecting to incur approx. $3.4 million in related costs. Additionally, key executives will leave their positions effective July 18, 2025, with severance agreements in place.